AS pharmacists both develop and embrace emerging technologies to support patients with dementia, a new funding round is now open to back innovations that could further transform care.
The second round of the CUREator Dementia and Cognitive Decline Incubator Program is inviting applications from biotech, medical device and digital health startups and companies focused on expanding treatment and wellbeing options for the thousands of Australians living with dementia.
The Federal Government-funded program, which is a partnership between Brandon BioCatalyst, ANDHealth, and Dementia Australia, offers up to $5 million per project - delivered in tranches upon reaching agreed milestones - and also provides access to digital health expertise.
Companies and startups interested in applying can tune into a webinar on 29 May to learn more (register here), while program applications close on 10 Jul (submit here).
The above article was sent to subscribers in Pharmacy Daily's issue from 23 May 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 May 25
